CaPtivate Pharmaceuticals LLC was incorporated in 2011 as a spin-off from BioSante Pharmaceuticals (currently ANI Pharmaceuticals).  It is a preclinical-stage biotechnology company based in greater Philadelphia - Pennsylvania Biotechnology Incubator, Doylestown PA. The company is focused on developing its proprietary CaP nanoparticle vaccine adjuvant and delivery platform (CaPtivant^TM) for advancement of novel and improved vaccines against life-treating diseases.

Establishing collaborations and partnerships within industrial, academic, non-profit, and government organizations is the foundation of CaPtivate’s business strategy. We actively seek partners in human and veterinary vaccine R&D who are searching for a safe and effective vaccine adjuvant/delivery system that enables:

• Broad spectrum of immune responses, including humoral, mucosal, CTL,
• Mucosal administrations including pulmonary, intranasal, intravaginal,
• Formulations as particulate suspension or as stable powders.